{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:31:13Z","timestamp":1794951073336,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Project of the Health Commission of Ningxia Hui Autonomous Region","award":["2024-NWZC-B002"],"award-info":[{"award-number":["2024-NWZC-B002"]}]},{"name":"Provincial key research and development program","award":["2023BEG02002"],"award-info":[{"award-number":["2023BEG02002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>This study aimed to investigate the effects of the interaction between ROP16 and TAF15 on apoptosis and cell cycle regulation in A549 lung adenocarcinoma cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Lentivirus-infected A549 cells which could overexpress type I, II, and III ROP16, along with an empty vector control group, were established. Potential interacting proteins with ROP16 were identified by using co-immunoprecipitation (Co-IP) and liquid chromatography-mass spectrometry (LC\u2013MS). High-scoring interacting proteins were selected for verification through Venn diagram analysis, scoring, and intensity evaluation. The interaction between ROP16 and TAF15 was confirmed by using co-immunoprecipitation. Moreover, TAF15-specific siRNA was synthesized and transfected into A549 cells overexpressing ROP16 types I, II, and III. The levels of apoptosis and cell cycle were detected by flow cytometry (FCM), and the expression levels of apoptosis-related proteins and cell cycle-related proteins were detected by real-time fluorescence quantitative PCR (RT-qPCR) and western blotting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Three stable A549 cell lines overexpressing type I, II, and III ROP16 were successfully established. IP-LC\/MS identified 29 potential ROP16-interacting proteins, among which 13 had a score greater than 100. Subsequent bioinformatic analysis and co-immunoprecipitation confirmed the interaction between ROP16 and TAF15. Flow cytometry analysis revealed that type I and III ROP16 promoted A549 cell apoptosis and induced cell cycle arrest. Furthermore, western blotting and RT-qPCR demonstrated their modulation of the expression of cell cycle regulators (p21, CDK6, Cyclin D1) and apoptosis-related proteins (Bax, BCL-2, p53, Caspase-9). In contrast, type II ROP16 exhibited none of these effects. However, upon TAF15 silencing, the pro-apoptotic effects of type I and III ROP16 were attenuated, no significant cell cycle arrest was observed, and their regulatory effects on the expression of cell cycle- and apoptosis-related proteins were also significantly diminished.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our study demonstrates that type I\/III ROP16 induce apoptosis and cell cycle arrest in A549 cells through interactions with the host RNA-binding protein TAF15. These findings not only provide compelling evidence for the oncosuppressive potential of <jats:italic>Toxoplasma gondii<\/jats:italic>-derived secretory proteins but also uncover a previously unrecognized mechanism by which parasite effectors hijack host transcriptional regulators to subvert cancer cell survival pathways.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13071-025-06933-6","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T12:14:28Z","timestamp":1752927268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TAF15 mediates ROP16-induced apoptosis and cell cycle arrest in lung cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Guangqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanni","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qirui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"6933_CR1","doi-asserted-by":"publisher","first-page":"8027","DOI":"10.1007\/s00432-023-04694-2","volume":"149","author":"M Yousefi","year":"2023","unstructured":"Yousefi M, Akbari M, Hadipour M, Dehkordi AB, Farahbakhsh Z, Darani HY. Parasites as potential targets for cancer immunotherapy. J Cancer Res Clin Oncol. 2023;149:8027\u201338. https:\/\/doi.org\/10.1007\/s00432-023-04694-2.","journal-title":"J Cancer Res Clin Oncol"},{"key":"6933_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering9080395","author":"H Ding","year":"2022","unstructured":"Ding H, Wu S, Jin Z, Zheng B, Hu Y, He K, et al. Anti-tumor effect of parasitic protozoans. Bioengineering. 2022;9 8:395. https:\/\/doi.org\/10.3390\/bioengineering9080395.","journal-title":"Bioengineering"},{"key":"6933_CR3","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20180935","author":"BE Callejas","year":"2018","unstructured":"Callejas BE, Mart\u00ednez-Saucedo D, Terrazas LI. Parasites as negative regulators of cancer. 2018;385:BSR20180935. Biosci Rep. https:\/\/doi.org\/10.1042\/bsr20180935."},{"key":"6933_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00115-19","author":"HM Elsheikha","year":"2021","unstructured":"Elsheikha HM, Marra CM, Zhu XQ. Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis. Clin Microbiol Rev. 2020;34 1:e00115\u201319. https:\/\/doi.org\/10.1128\/cmr.00115-19.","journal-title":"Clin Microbiol Rev"},{"key":"6933_CR5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s13071-021-05032-6","volume":"14","author":"LQ Xu","year":"2021","unstructured":"Xu LQ, Yao LJ, Jiang D, Zhou LJ, Chen M, Liao WZ, et al. A uracil auxotroph Toxoplasma gondii exerting immunomodulation to inhibit breast cancer growth and metastasis. Parasit Vectors. 2021;14:601. https:\/\/doi.org\/10.1186\/s13071-021-05032-6.","journal-title":"Parasit Vectors"},{"key":"6933_CR6","doi-asserted-by":"publisher","first-page":"959300","DOI":"10.3389\/fcimb.2022.959300","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Liao W, Peng H. Toxoplasma gondii infection possibly reverses host immunosuppression to restrain tumor growth. Front Cell Infect Microbiol. 2022;12:959300. https:\/\/doi.org\/10.3389\/fcimb.2022.959300.","journal-title":"Front Cell Infect Microbiol"},{"key":"6933_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"6933_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/s0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398:535\u201354. https:\/\/doi.org\/10.1016\/s0140-6736(21)00312-3.","journal-title":"Lancet"},{"key":"6933_CR9","first-page":"5","volume":"110","author":"E Kuhn","year":"2018","unstructured":"Kuhn E, Morbini P, Cancellieri A, Damiani S, Cavazza A, Comin CE. Adenocarcinoma classification: patterns and prognosis. Pathologica. 2018;110:5\u201311.","journal-title":"Pathologica"},{"key":"6933_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.semcancer.2022.03.006","volume":"86","author":"X Yin","year":"2022","unstructured":"Yin X, Li Y, Wang H, Jia T, Wang E, Luo Y, et al. Small cell lung cancer transformation: from pathogenesis to treatment. Semin Cancer Biol. 2022;86:595\u2013606. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.006.","journal-title":"Semin Cancer Biol"},{"key":"6933_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354. https:\/\/doi.org\/10.1038\/nature25183.","journal-title":"Nature"},{"key":"6933_CR12","doi-asserted-by":"publisher","first-page":"102237","DOI":"10.1016\/j.ctrv.2021.102237","volume":"99","author":"L Succony","year":"2021","unstructured":"Succony L, Rassl DM, Barker AP, McCaughan FM, Rintoul RC. Adenocarcinoma spectrum lesions of the lung: detection, pathology and treatment strategies. Cancer Treat Rev. 2021;99:102237. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102237.","journal-title":"Cancer Treat Rev"},{"key":"6933_CR13","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","volume":"94","author":"N Duma","year":"2019","unstructured":"Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019;94:1623\u201340. https:\/\/doi.org\/10.1016\/j.mayocp.2019.01.013.","journal-title":"Mayo Clin Proc"},{"key":"6933_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","volume":"19","author":"AJ Cooper","year":"2022","unstructured":"Cooper AJ, Sequist LV, Lin JJ. Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management. Nat Rev Clin Oncol. 2022;19:499\u2013514. https:\/\/doi.org\/10.1038\/s41571-022-00639-9.","journal-title":"Nat Rev Clin Oncol"},{"key":"6933_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/jco.21.01626","volume":"40","author":"AC Tan","year":"2022","unstructured":"Tan AC, Tan DSW. Targeted therapies for lung cancer patients with oncogenic driver molecular alterations. J Clin Oncol. 2022;40:611\u201325. https:\/\/doi.org\/10.1200\/jco.21.01626.","journal-title":"J Clin Oncol"},{"key":"6933_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijpara.2013.08.002","volume":"44","author":"A Camejo","year":"2014","unstructured":"Camejo A, Gold DA, Lu D, McFetridge K, Julien L, Yang N, et al. Identification of three novel Toxoplasma gondii rhoptry proteins. Int J Parasitol. 2014;44:147\u201360. https:\/\/doi.org\/10.1016\/j.ijpara.2013.08.002.","journal-title":"Int J Parasitol"},{"key":"6933_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrmicro1800","volume":"6","author":"JC Boothroyd","year":"2008","unstructured":"Boothroyd JC, Dubremetz JF. Kiss and spit: the dual roles of Toxoplasma rhoptries. Nat Rev Microbiol. 2008;6:79\u201388. https:\/\/doi.org\/10.1038\/nrmicro1800.","journal-title":"Nat Rev Microbiol"},{"key":"6933_CR18","doi-asserted-by":"publisher","first-page":"e1002236","DOI":"10.1371\/journal.ppat.1002236","volume":"7","author":"BA Butcher","year":"2011","unstructured":"Butcher BA, Fox BA, Rommereim LM, Kim SG, Maurer KJ, Yarovinsky F, et al. Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog. 2011;7:e1002236. https:\/\/doi.org\/10.1371\/journal.ppat.1002236.","journal-title":"PLoS Pathog"},{"key":"6933_CR19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.pt.2024.03.008","volume":"40","author":"J Yang","year":"2024","unstructured":"Yang J, Long S, Hide G, Lun ZR, Lai DH. Apicomplexa micropore: history, function, and formation. Trends Parasitol. 2024;40:416\u201326. https:\/\/doi.org\/10.1016\/j.pt.2024.03.008.","journal-title":"Trends Parasitol"},{"key":"6933_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature05395","volume":"445","author":"JP Saeij","year":"2007","unstructured":"Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, Boothroyd JC. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature. 2007;445:324\u20137. https:\/\/doi.org\/10.1038\/nature05395.","journal-title":"Nature"},{"key":"6933_CR21","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.7150\/ijbs.10516","volume":"11","author":"S Chang","year":"2015","unstructured":"Chang S, Shan X, Li X, Fan W, Zhang SQ, Zhang J, et al. Toxoplasma gondii Rhoptry Protein ROP16 mediates partially SH-SY5Y cells apoptosis and cell cycle arrest by directing Ser15\/37 phosphorylation of p53. Int J Biol Sci. 2015;11:1215\u201325. https:\/\/doi.org\/10.7150\/ijbs.10516.","journal-title":"Int J Biol Sci"},{"key":"6933_CR22","doi-asserted-by":"publisher","first-page":"6634","DOI":"10.3748\/wjg.v25.i45.6634","volume":"25","author":"YW Xu","year":"2019","unstructured":"Xu YW, Xing RX, Zhang WH, Li L, Wu Y, Hu J, et al. Toxoplasma ROP16(I\/III) ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages. World J Gastroenterol. 2019;25:6634\u201352. https:\/\/doi.org\/10.3748\/wjg.v25.i45.6634.","journal-title":"World J Gastroenterol"},{"key":"6933_CR23","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.3892\/mmr.2016.5758","volume":"14","author":"W Fan","year":"2016","unstructured":"Fan W, Chang S, Shan X, Gao D, Zhang SQ, Zhang J, et al. Transcriptional profile of SH-SY5Y human neuroblastoma cells transfected by Toxoplasma rhoptry protein 16. Mol Med Rep. 2016;14:4099\u2013108. https:\/\/doi.org\/10.3892\/mmr.2016.5758.","journal-title":"Mol Med Rep"},{"key":"6933_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12967-023-04020-x","volume":"21","author":"B Wang","year":"2023","unstructured":"Wang B, Chen H, Deng Y, Chen H, Xing L, Guo Y, et al. CircDNAJC11 interacts with TAF15 to promote breast cancer progression via enhancing MAPK6 expression and activating the MAPK signaling pathway. J Transl Med. 2023;21:186. https:\/\/doi.org\/10.1186\/s12967-023-04020-x.","journal-title":"J Transl Med"},{"key":"6933_CR25","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.18632\/oncotarget.27663","volume":"11","author":"AK Singh","year":"2020","unstructured":"Singh AK, Kapoor V, Thotala D, Hallahan DE. TAF15 contributes to the radiation-inducible stress response in cancer. Oncotarget. 2020;11:2647\u201359. https:\/\/doi.org\/10.18632\/oncotarget.27663.","journal-title":"Oncotarget"},{"key":"6933_CR26","doi-asserted-by":"publisher","first-page":"28731","DOI":"10.1074\/jbc.M110.112359","volume":"285","author":"YC Ong","year":"2010","unstructured":"Ong YC, Reese ML, Boothroyd JC. Toxoplasma rhoptry protein 16 (ROP16) subverts host function by direct tyrosine phosphorylation of STAT6. J Biol Chem. 2010;285:28731\u201340. https:\/\/doi.org\/10.1074\/jbc.M110.112359.","journal-title":"J Biol Chem"},{"key":"6933_CR27","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1084\/jem.20091703","volume":"206","author":"M Yamamoto","year":"2009","unstructured":"Yamamoto M, Standley DM, Takashima S, Saiga H, Okuyama M, Kayama H, et al. A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. J Exp Med. 2009;206:2747\u201360. https:\/\/doi.org\/10.1084\/jem.20091703.","journal-title":"J Exp Med"},{"key":"6933_CR28","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1126\/science.1133690","volume":"314","author":"JP Saeij","year":"2006","unstructured":"Saeij JP, Boyle JP, Coller S, Taylor S, Sibley LD, Brooke-Powell ET, et al. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science. 2006;314:1780\u20133. https:\/\/doi.org\/10.1126\/science.1133690.","journal-title":"Science"},{"key":"6933_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1084\/jem.20100717","volume":"208","author":"EE Rosowski","year":"2011","unstructured":"Rosowski EE, Lu D, Julien L, Rodda L, Gaiser RA, Jensen KD, et al. Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J Exp Med. 2011;208:195\u2013212. https:\/\/doi.org\/10.1084\/jem.20100717.","journal-title":"J Exp Med"},{"key":"6933_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13071-021-05003-x","volume":"15","author":"D Jiang","year":"2022","unstructured":"Jiang D, Wu S, Xu L, Xie G, Li D, Peng H. Anti-infection roles of miR-155\u20135p packaged in exosomes secreted by dendritic cells infected with Toxoplasma gondii. Parasit Vectors. 2022;15:3. https:\/\/doi.org\/10.1186\/s13071-021-05003-x.","journal-title":"Parasit Vectors"},{"key":"6933_CR31","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1111\/liv.15607","volume":"43","author":"S Yang","year":"2023","unstructured":"Yang S, Xu B, Han Y, Jiang M, Luo T, Wu N, et al. TAF15 exacerbates nonalcoholic steatohepatitis progression by regulating lipid metabolism and inflammation via FASN and p65 NF-\u03baB. Liver Int. 2023;43:1920\u201336. https:\/\/doi.org\/10.1111\/liv.15607.","journal-title":"Liver Int"},{"key":"6933_CR32","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1038\/onc.2012.490","volume":"32","author":"M Ballarino","year":"2013","unstructured":"Ballarino M, Jobert L, Demb\u00e9l\u00e9 D, de la Grange P, Auboeuf D, Tora L. TAF15 is important for cellular proliferation and regulates the expression of a subset of cell cycle genes through miRNAs. Oncogene. 2013;32:4646\u201355. https:\/\/doi.org\/10.1038\/onc.2012.490.","journal-title":"Oncogene"},{"key":"6933_CR33","doi-asserted-by":"publisher","first-page":"111513","DOI":"10.1016\/j.celrep.2022.111513","volume":"41","author":"Z Su","year":"2022","unstructured":"Su Z, Sun Z, Wang Z, Wang S, Wang Y, Jin E, et al. TIF1\u03b3 inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15\/TBP complex. Cell Rep. 2022;41:111513. https:\/\/doi.org\/10.1016\/j.celrep.2022.111513.","journal-title":"Cell Rep"},{"key":"6933_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2217\/epi-2022-0432","volume":"15","author":"W Peng","year":"2023","unstructured":"Peng W, Jiang J, Fu J, Duan H, Wang J, Duan C. lncRNA GMDS-AS1 restrains lung adenocarcinoma progression via recruiting TAF15 protein to stabilize SIRT1 mRNA. Epigenomics. 2023;15:417\u201334. https:\/\/doi.org\/10.2217\/epi-2022-0432.","journal-title":"Epigenomics"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06933-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-06933-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06933-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T12:14:29Z","timestamp":1752927269000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-06933-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6933"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-06933-6","relation":{"references":[{"id-type":"doi","id":"10.1042\/bsr20180935","asserted-by":"subject"}]},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by Ningxia Medical University General Hospital Scientific Research Ethics Committee (KYLL-2024\u20130113).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}